MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Parkinson’s disease-associated Miro1 mutants cause mitochondrial dysfunction

D. Grossmann, D. Scheibner, J. Fitzgerald, W. Mätzler, L. Burbulla, R. Krüger (Belvaux, Luxembourg)

Meeting: 2016 International Congress

Abstract Number: 710

Keywords: Familial neurodegenerative diseases, Mitochondria, Parkinsonism

Session Information

Date: Tuesday, June 21, 2016

Session Title: Therapy in movement disorders: Gene and cell-based therapies

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: In the present study we dissected the role of the first PD-associated mutations in RhoT1, the gene encoding for Miro1.

Background: Commonly involved pathogenic pathways are linked to mitochondrial dysfunction, e.g. increased oxidative stress, disruption of calcium homeostasis and decreased energy supply. A very important protein for mitochondrial distribution, quality control and maintenance is Miro1. To date Miro1 is not established as risk factor for PD.

Methods: In the present study we dissected the role of the first PD-associated mutations in RhoT1, using a comprehensive mutation screening of RhoT1 in German PD patients. Three mutations in RhoT1 have been identified in three PD patients with positive family history for PD. For analysis of mitochondrial phenotypes patient-derived fibroblasts were immortalized. As independent cell model served M17 cells with stable knock-down of endogenous RhoT1 and transiently overexpression of the RhoT1 mutant variants.

Results: Three mutations have been identified in three PD patients with positive family history for PD. Interestingly, the Miro1 protein amount was significantly reduced in Miro1-R>Q and Miro1-R>C mutant fibroblast lines compared to controls. Functional analysis revealed that mitochondrial mass was reduced in Miro1-R>C, but not in Miro1-R>Q fibroblasts. Furthermore, MnSOD was decreased in Miro1-R>C fibroblasts, although mitochondrial biogenesis was increased, as indicated by increased levels of PGC-1α. A similar phenotype with reduction of mitochondrial mass and MnSOD protein amount was also observed in neuroblastoma (M17) cells overexpressing Miro1-R>Q and Miro1-R>C. Additionally, respiratory activity was reduced in Miro1-R>Q fibroblasts compared to Miro1-R>C fibroblasts. Our findings suggest that Miro1-R>Q leads to impaired mitochondrial respiration. In contrast, Miro1-R>C fibroblasts showed increased respiration compared to Miro1-R>Q fibroblasts, despite citrate synthase activity was significantly reduced. Both alterations of respiratory activity lead to mitochondrial membrane hyperpolarization in Miro1-R>Q and Miro1-R>C fibroblasts.

Conclusions: Our study on functional consequences of variants in RhoT1 further underscores the relevance of mitochondrial function and dynamics in PD and indicates that RhoT1 might be a novel risk gene in PD.

To cite this abstract in AMA style:

D. Grossmann, D. Scheibner, J. Fitzgerald, W. Mätzler, L. Burbulla, R. Krüger. Parkinson’s disease-associated Miro1 mutants cause mitochondrial dysfunction [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/parkinsons-disease-associated-miro1-mutants-cause-mitochondrial-dysfunction/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/parkinsons-disease-associated-miro1-mutants-cause-mitochondrial-dysfunction/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley